Results 11 to 20 of about 1,266,387 (240)

Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway

open access: yesFrontiers in Oncology, 2022
Primary liver cancer is the sixth most frequently diagnosed cancer worldwide and the third leading cause of cancer-related death. The majority of the primary liver cancer cases are hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Geofrey Mahiki Mranda   +4 more
doaj   +1 more source

High-Intensity Focused Ultrasound Ablation for Unresectable Primary and Metastatic Liver Cancer: Real-World Research in a Chinese Tertiary Center With 275 Cases

open access: yesFrontiers in Oncology, 2020
This retrospective analysis was conducted to evaluate the feasibility and safety of high-intensity focused ultrasound ablation for primary liver cancer and metastatic liver cancer. Patients with liver cancer who received high-intensity focused ultrasound
Yongshuo Ji   +4 more
doaj   +1 more source

Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch databaseResearch in context

open access: yesEClinicalMedicine, 2023
Summary: Background: Liver cancer has one of the fastest rising incidence and mortality rates among all cancers in the UK, but it receives little attention.
Weiqi Liao   +28 more
doaj   +1 more source

Comment on "Research on values of GDF-15 level in the diagnosis of primary liver cancer and evaluation of chemotherapeutic effect" [PDF]

open access: yes, 2019
Comment on research on values of GDF-15 level in the diagnosis of primary liver cancer and evaluation of chemotherapeutic ...
Berretta, S, Fisichella, R, Izzo, L
core   +1 more source

Research Progress in Epidemiology and Risk Factors of Primary Liver Cancer [PDF]

open access: yesZhongguo quanke yixue
Primary liver cancer is one of the common cancers in the world and with extremely high morbidity and mortality. This paper details the current epidemiology of primary liver cancer, population attributable fractions and associated risk factors in China ...
CHEN Qianqian, RUI Fajuan, NI Wenjing, LI Jie
doaj   +1 more source

β-caryophyllene and low-doses of doxorubicin against liver cancer cells: a “metronomic chemotherapy” [PDF]

open access: yes, 2017
Cholangiocarcinoma and hepatocellular carcinoma are primary liver cancers, both representing a growing challenge due to their increasing morbidity and mortality.
Abete, Lorena   +7 more
core   +4 more sources

Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer

open access: yesCanadian Journal of Gastroenterology and Hepatology, 2023
Background. The drug-eluting beads transarterial chemoembolization (DEB-TACE) has already been used in hepatic malignancies. We aim to evaluate the efficacy and safety of DEB-TACE in treating primary or secondary liver cancer. Methods. We retrospectively
Jiabing Wang   +4 more
doaj   +1 more source

Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review. [PDF]

open access: yes, 2016
Hepatocellular carcinoma is the most common primary liver cancer and it represents the majority of cancer-related deaths in the world. More than 70% of patients present at an advanced stage, beyond potentially curative options.
Alanis, Lourdes   +3 more
core   +1 more source

Primary liver cancer [PDF]

open access: yesBritish Journal of Cancer, 2013
As several of the contributors point out in their introductory paragraphs, hepatocellular cancer (HCC) is the sixth most common cancer, and the third most common cause of cancer death worldwide. The majority of patients have co-existent liver disease and, in some patients, advanced cirrhosis may be the life-limiting disease rather than cancer.
openaire   +1 more source

Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival

open access: yesBMC Gastroenterology, 2008
Background The tumour suppressor phosphatase and tensin homolog (PTEN) is an important negative regulator of cell-survival signaling. To evaluate the correlation between PTEN expression and clinicopathological characteristics of colorectal cancer ...
Funahashi Hitoshi   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy